Cargando…

Molecular Characterization of Prostate Cancers in the Precision Medicine Era

SIMPLE SUMMARY: Prostate cancer research has been recently characterized by the discovery of several prognostic and predictive molecular factors, which ultimately improve patients’ management. In this review, we present the clinical impact of such factors and the methods to detect them, both on tiss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giunta, Emilio Francesco, Annaratone, Laura, Bollito, Enrico, Porpiglia, Francesco, Cereda, Matteo, Banna, Giuseppe Luigi, Mosca, Alessandra, Marchiò, Caterina, Rescigno, Pasquale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507555/ https://www.ncbi.nlm.nih.gov/pubmed/34638258 http://dx.doi.org/10.3390/cancers13194771

Ejemplares similares

Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence
por: Rebuzzi, Sara Elena, et al.
Publicado: (2021)

A Fully Automatic Artificial Intelligence System Able to Detect and Characterize Prostate Cancer Using Multiparametric MRI: Multicenter and Multi-Scanner Validation
por: Giannini, Valentina, et al.
Publicado: (2021)

First-Line Treatment for Advanced SCLC: What Is Left Behind and Beyond Chemoimmunotherapy
por: Giunta, Emilio Francesco, et al.
Publicado: (2022)

Basic principles of biobanking: from biological samples to precision medicine for patients
por: Annaratone, Laura, et al.
Publicado: (2021)

Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network
por: Rescigno, Pasquale, et al.
Publicado: (2022)

The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network
por: Banna, Giuseppe Luigi, et al.
Publicado: (2022)

Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine
por: Dulaney, Caleb R., et al.
Publicado: (2016)

Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer
por: Ramroop, Johnny R., et al.
Publicado: (2018)

A New Era of Prostate Cancer Precision Medicine
por: Malik, Adil, et al.
Publicado: (2019)

Colon Rectal Liver Metastases: The Role of the Liver Transplantation in the Era of the Transplant Oncology and Precision Medicine
por: Finotti, Michele, et al.
Publicado: (2021)

Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer
por: Lo Iacono, Marco, et al.
Publicado: (2016)

Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives
por: Rebuzzi, Sara Elena, et al.
Publicado: (2022)

Exploring Small Extracellular Vesicles for Precision Medicine in Prostate Cancer
por: Giulietti, Matteo, et al.
Publicado: (2018)

New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era
por: Leone, Augusto, et al.
Publicado: (2022)

Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer
por: Porpiglia, Francesco, et al.
Publicado: (2015)

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
por: Fujimura, Tetsuya, et al.
Publicado: (2018)

The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine
por: Lewis, Deyana D., et al.
Publicado: (2020)

Beyond Crizotinib: A Systematic Review and Meta-Analysis of the Next-Generation ALK Inhibitors as First-Line Treatment for ALK-Translocated Lung Cancer
por: Giunta, Emilio Francesco, et al.
Publicado: (2022)

Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling
por: Annaratone, Laura, et al.
Publicado: (2013)

Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine
por: Suh, Yoon Seok, et al.
Publicado: (2017)

MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine
por: Smith, Bethany, et al.
Publicado: (2017)

Management of Advanced Prostate Cancer in the Precision Oncology Era
por: Gillette, Claire M., et al.
Publicado: (2023)

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas
por: Berrino, Enrico, et al.
Publicado: (2022)

Nuclear Medicine in Prostate Cancer: A New Era for Radiotracers
por: Cuccurullo, Vincenzo, et al.
Publicado: (2018)

The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review
por: Rizzo, Alessio, et al.
Publicado: (2023)

Precision Imaging Guidance in the Era of Precision Oncology: An Update of Imaging Tools for Interventional Procedures
por: Floridi, Chiara, et al.
Publicado: (2022)

Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020)

Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples
por: Bussolati, Gianni, et al.
Publicado: (2017)

New Potential Immune Biomarkers in the Era of Precision Medicine: Lights and Shadows in Colorectal Cancer
por: Damato, Angela, et al.
Publicado: (2022)

Precision Medicine: The new era in medicine
por: Twilt, Marinka
Publicado: (2016)

Do we still need breast cancer screening in the era of targeted therapies and precision medicine?
por: Trimboli, Rubina Manuela, et al.
Publicado: (2020)

Three-dimensional automatic artificial intelligence driven augmented-reality selective biopsy during nerve-sparing robot-assisted radical prostatectomy: A feasibility and accuracy study
por: Checcucci, Enrico, et al.
Publicado: (2023)

Traditional and Virtual Congress Meetings During the COVID-19 Pandemic and the Post-COVID-19 Era: Is it Time to Change the Paradigm?
por: Porpiglia, Francesco, et al.
Publicado: (2020)

Gene expression profiles and treatments for metastatic renal cell carcinoma: What does still need to be defined?
por: Giunta, Emilio F., et al.
Publicado: (2022)

Precision Medicine in Osteosarcoma: MATCH Trial and Beyond
por: Tirtei, Elisa, et al.
Publicado: (2021)

Multimodality Imaging for Atrial Fibrosis Detection in the Era of Precision Medicine
por: Barletta, Valentina, et al.
Publicado: (2021)

INOSA Guidelines in the era of precision medicine
por: Chakraborty, Ranajit
Publicado: (2015)

Cardiovascular Precision Medicine in the Genomics Era
por: Dainis, Alexandra M., et al.
Publicado: (2018)

Gastric Cancer in the Era of Precision Medicine
por: Liu, Xi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fh1r0q3cakms16tnj62ass51bg